MALPEZZI, GIULIA
 Distribuzione geografica
Continente #
AS - Asia 2.122
NA - Nord America 1.397
EU - Europa 1.393
SA - Sud America 243
AF - Africa 57
OC - Oceania 8
Totale 5.220
Nazione #
US - Stati Uniti d'America 1.346
CN - Cina 740
SG - Singapore 592
IT - Italia 497
VN - Vietnam 193
BR - Brasile 192
HK - Hong Kong 182
DE - Germania 176
KR - Corea 132
GB - Regno Unito 130
SE - Svezia 120
FR - Francia 80
RU - Federazione Russa 79
FI - Finlandia 58
ID - Indonesia 48
IN - India 45
ES - Italia 44
NL - Olanda 39
JP - Giappone 32
CA - Canada 29
BE - Belgio 27
IQ - Iraq 25
CH - Svizzera 22
LT - Lituania 22
BD - Bangladesh 21
PL - Polonia 18
ZA - Sudafrica 15
AR - Argentina 14
IR - Iran 14
AT - Austria 13
TR - Turchia 13
MX - Messico 12
CL - Cile 11
IE - Irlanda 11
CZ - Repubblica Ceca 10
MY - Malesia 10
SA - Arabia Saudita 10
TW - Taiwan 10
UZ - Uzbekistan 10
EC - Ecuador 9
MA - Marocco 9
PH - Filippine 8
PK - Pakistan 8
PY - Paraguay 7
TN - Tunisia 7
UA - Ucraina 7
AU - Australia 6
DZ - Algeria 6
VE - Venezuela 6
ET - Etiopia 5
KE - Kenya 5
BY - Bielorussia 4
EG - Egitto 4
GR - Grecia 4
HU - Ungheria 4
KZ - Kazakistan 4
LI - Liechtenstein 4
NO - Norvegia 4
PT - Portogallo 4
RS - Serbia 4
AZ - Azerbaigian 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
IL - Israele 3
JO - Giordania 3
MO - Macao, regione amministrativa speciale della Cina 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BH - Bahrain 2
CR - Costa Rica 2
GH - Ghana 2
JM - Giamaica 2
LB - Libano 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SN - Senegal 2
TH - Thailandia 2
BO - Bolivia 1
CO - Colombia 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
NG - Nigeria 1
NP - Nepal 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
UY - Uruguay 1
Totale 5.220
Città #
Hefei 379
Singapore 371
Santa Clara 328
Hong Kong 174
Ashburn 173
San Jose 154
Seoul 119
Modena 77
Ho Chi Minh City 71
Frankfurt am Main 67
London 66
Beijing 60
Council Bluffs 44
Los Angeles 44
The Dalles 39
Jakarta 38
Munich 38
Hanoi 37
Helsinki 37
New York 37
Milan 36
Nyköping 33
Bologna 30
Chandler 26
Lauterbourg 26
Parma 22
Reggio Emilia 22
Kent 21
Orem 21
Moscow 20
Boardman 19
Shanghai 19
Amsterdam 18
Padova 17
Buffalo 16
Warsaw 16
Dallas 15
Leuven 15
São Paulo 15
Hangzhou 14
Barcelona 13
Decatur 13
Lappeenranta 13
Madrid 13
Chennai 12
Chicago 12
Zurich 11
Da Nang 10
Manchester 10
Rome 10
Tehran 10
Boston 9
Brussels 9
Santiago 9
Tashkent 9
Tokyo 9
Brooklyn 8
Dublin 8
Formigine 8
Nuremberg 8
Phoenix 8
Stockholm 8
Vienna 8
Argenta 7
Biên Hòa 7
Denver 7
Kuala Lumpur 7
Montreal 7
Ottawa 7
Poplar 7
Atlanta 6
Belo Horizonte 6
Brno 6
Charlotte 6
East Wenatchee 6
Guangzhou 6
Johannesburg 6
Leipzig 6
Mexico City 6
Osnabrück 6
Princeton 6
Rossdorf 6
Turku 6
Washington 6
Addis Ababa 5
Ankara 5
Cebu City 5
Ferrara 5
Hillsboro 5
Juiz de Fora 5
Marseille 5
Paris 5
Piacenza 5
Portsmouth 5
Raleigh 5
Rio de Janeiro 5
Riyadh 5
San Diego 5
Seattle 5
Toronto 5
Totale 3.215
Nome #
Designing selective Cys-ligands to unpair the binding of the Human Transcription Enhancer Associated Domain 4 (hTEAD-4) with its modulators to halt cancer cell growth 276
Exploiting Forster Resonance Energy Transfer (FRET) in the characterization of YAP:TEAD complex disruption 256
design, synthesis and biological evaluation of novel YAP:TEAD complex disruptors for thetreatment of colorectal cancer 233
A toolbox of biophysical and analytical assays helps to confirm the activity of novel hTS dimer disrupters (Ddis) with anticancer properties 230
Development of a novel class of YAP:TEAD interface-3 molecular disruptors to treat colorectal carcinoma 227
Applying optical tweezers technology to reveal Thymidylate Synthase interactions with its consensus mRNA 211
Current Treatments to Control African Trypanosomiasis and One Health Perspective 206
Lead optimization of human thymidylate synthase dimer disrupters: from computational studies to evaluation of their biological profiles 195
Lead-optimization process and characterization of the dissociative effect applied to new dimer disrupters of human Thymidylate Synthase 185
Exploring thymidylate synthase mRNA binding site 1 and human TS protein interaction with optical tweezers and bicistronic expression assay 183
UHPLC-MS/MS screening of the hTEAD surface for the identification of novel allosteric inhibitors with anticancer activity 179
Advancing sustainable drug development: comparative preclinical study of H80 and Miltefosine using imaging and proteomics 175
EXPLOITING THE OPTICAL TWEEZER, A SINGLE MOLECULE TECHNOLOGY, TO REVEAL THYMIDYLATE SYNTHASE INTERACTIONS WITH ITS CONSENSUS mRNA 173
Intersite Communication in Dimeric Enzymes Highlighted by Structural and Thermodynamic Analysis of Didansyltyrosine Binding to Thymidylate Synthases 172
Exploiting the Optical Tweezer technology to reveal thymidylate synthase interactions with its consensus mRNA 170
Insights into host-target interaction from the proteome modulation analysis through untargeted LC-MS/MS Proteomics of drug resistant L infantum-THP1 infected cells 164
Leveraging proteomic, bioinformatic and ecotoxicology models to select new targets overcoming L. Infantum drug resistent 162
LC-MS/MS proteomics for the rapid and selective screening of drug resistances in Leishmania infantum clinical isolates 161
Deciphering Host–Parasite Interplay in Leishmania Infection through a One Health View of Proteomics Studies on Drug Resistance 159
Investigating the mechanism of action of the antiparasitic agent H80 through imaging techniques 157
Optical tweezers to investigate at the single-molecule level the interaction of thymidylate synthase with its consensus mRNA 152
Optimization of chemical-biological tools for characterizing the activity of dissociative inhibitor of human thymidylate synthase 146
One Health Approach in Drug Discovery for Leishmaniasis by Targeting Calpain cys-protease. 145
Drug discovery of pyrazolo-piperidinone inhibitors targeting YAP:TEAD interaction and development of a fluorescence anisotropy assay for high-throughput screening 144
MS Proteomics And Biochemical Characterization Of Thymidylate Synthase Dimer Destabilizer E7 To Halt Colorectal Carcinoma 135
Promoting A Sustainable Medicinal Chemistry Approach With The Cost Action CA21111 - One Health Drugs Against Parasitic Vector Borne Diseases In Europe And Beyond 130
Leveraging proteomics, bioinformatics, and ecotoxicology models to select new targets overcoming L infantum drug resistance. 127
Targeting of the Cysteines Surface domain of the Transcriptional Enhancer Associate Domain (TEAD) for anticancer drug discovery 119
Preclinical investigation of H80 compared to miltefosine: imaging and proteomics for sustainable drug development 104
Development of a fluorescent anisotropy displacement assay for the optimization of YAP:TEAD molecular disrupters with anticancer activity 85
IDENTIFICATION OF PYRAZOLO-PIPERIDINONE DERIVATIVES TARGETING YAP-TEAD INTERFACE 3 AS ANTICANCER AGENTS THROUGH INTEGRATED VIRTUAL SCREENING AND MASS SPECTROMETRY PROTEOMICS 73
Meccanismi on-target di farmaci innovativi antitumorali e anti-infettivi studiati mediante approcci biochimici e biofisici 21
Totale 5.255
Categoria #
all - tutte 17.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.310


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 0 0 0 17 9 6 12 4 22 13
2022/2023272 35 23 14 18 13 20 18 35 50 1 31 14
2023/2024651 38 43 47 28 146 38 65 54 16 9 98 69
2024/20251.723 55 33 64 101 290 252 135 89 169 70 249 216
2025/20262.526 252 209 284 353 322 143 354 131 247 231 0 0
Totale 5.255